stocks of Dr Reddy’s Laboratories fell as plenty as 2.24 per cent to hit intraday low of Rs three,062 after Reuters pronounced that an US organisation has charged India’s 2d largest pharma organization for packaging lapses.
Reuters stated that US patron Product protection commission charged the Hyderabad-based drugmaker for failing to conform with regulations on baby-resistant packaging for 5 of its merchandise.
The employer, however, stated it “firmly disagrees with the (US) authorities‘s allegations,” and introducedit would retain cooperating with US government, the Reuters report brought.
stocks of Dr Reddy’s Labs ended 2.thirteen in line with cent decrease at Rs 3,071.
tale first posted on: June 09, 2016 14:48 (IST)
Tags: Dr Reddy’s Labs, US consumer Product safety fee, Packaging Lapses, Dr Reddy’s Laboratories stocks
